Aczone and Back pain aggravated - a phase IV clinical study of FDA data

Summary:

Back pain aggravated is reported as a side effect among people who take Aczone (dapsone), especially for people who are female, 30-39 old, have been taking the drug for 1 - 6 months also take Macrodantin, and have Behcet's syndrome.

The phase IV clinical study analyzes which people have Back pain aggravated when taking Aczone. It is created by eHealthMe based on reports of 1,126 people who have side effects when taking Aczone from the FDA, and is updated regularly.

What is Aczone?

Aczone has active ingredients of dapsone. It is often used in acne. eHealthMe is studying from 1,152 Aczone users. Check the latest studies of Aczone.

What is Back pain aggravated?

Back pain aggravated is found to be associated with 3,358 drugs and 2,100 conditions by eHealthMe. Check the latest studies of Back pain aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

1,126 people reported to have side effects when taking Aczone.
Among them, 20 people (1.78%) have Back pain aggravated.

Could Aczone cause Back pain aggravated?

Among these 20 people:

How long have people been on Aczone when they have Back pain aggravated? *

What is the gender of people who have Back pain aggravated when taking Aczone? *

female: 93.75 %
male: 6.25 %

What is the age of people who have Back pain aggravated when taking Aczone? *

What are other drugs people take besides Aczone? *

What are other side effects people have besides Back pain aggravated? *

Urinary Tract Infection: 8 people, 40.00%
Heart Attack: 6 people, 30.00%
Infection: 6 people, 30.00%
Eye Infection: 6 people, 30.00%
Sleep Attacks: 6 people, 30.00%
Muscle Strain (an injury to a muscle in which the muscle fibres tear): 6 people, 30.00%
Joint Pain: 4 people, 20.00%
High Blood Pressure: 4 people, 20.00%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 20.00%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 4 people, 20.00%

What are the existing conditions these people have? *

Behcet's Syndrome (involves inflammation of the blood vessels): 6 people, 30.00%
Urinary Tract Infection: 4 people, 20.00%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 10.00%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 5.00%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 5.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.00%
Birth Control: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Aczone and have Back pain aggravated?

- Check whether Back pain aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aczone:

Aczone (1,152 reports)

Browse all side effects of Aczone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Back pain aggravated:

Back pain aggravated (3,358 drugs)

Browse all the conditions that are associated with Back pain aggravated:

Back pain aggravated (2,100 conditions)

Related publications that referenced our studies

Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on dapsone (the active ingredients of Aczone) and Aczone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.